﻿                         SEQUENCE LISTING

<110>  Sanofi-Aventis Deutschland GmbH
 
<120>  Treatment of type 2 diabetes mellitus patients

<130>  59868P WO

<150>  EP 15159064.3
<111>  2015-03-13

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  44
<212>  PRT
<213>  Artificial

<220>
<223>  desPro36-Exendin-4(1-39)-Lys6-NH2

<400>  1

His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
1               5                   10                  15      


Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Ser Lys Lys Lys Lys Lys Lys 
        35                  40                  


<210>  2
<211>  39
<212>  PRT
<213>  Heloderma suspectum

<220>
<223>  Exendin-4-NH2

<400>  2

His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu 
1               5                   10                  15      


Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser 
            20                  25                  30          


Ser Gly Ala Pro Pro Pro Ser 
        35                  


